Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-25 4:16 pm Purchase | 13D | Cidara Therapeutics Inc. CDTX | RA CAPITAL MANAGEMENT L.P. | 703,080 9.99% | 703,080 (New Position) | View |
| 2024-07-08 4:17 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC. RXRX | RA CAPITAL MANAGEMENT L.P. | 15,384,615 5.9% | 15,384,615 (New Position) | View |
| 2024-07-01 9:31 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | RA CAPITAL MANAGEMENT L.P. | 1,235,599 7.2% | 1,235,599 (New Position) | View |
| 2024-07-01 9:28 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 31,459,267 47.1% | 18,268,418 (+138.49%) | View |
| 2024-06-24 5:06 pm Purchase | 13G | Perceptive Capital Solutions Corp PCSC | RA CAPITAL MANAGEMENT L.P. | 750,000 8.4% | 750,000 (New Position) | View |
| 2024-06-20 6:00 pm Purchase | 13D | Aerovate Therapeutics Inc. AVTE | RA CAPITAL MANAGEMENT L.P. | 9,242,092 32% | 928,110 (+11.16%) | View |
| 2024-06-17 8:50 pm Purchase | 13G | Evolent Health Inc. EVH | RA CAPITAL MANAGEMENT L.P. | 8,279,103 7.1% | 8,279,103 (New Position) | View |
| 2024-06-12 6:26 pm Purchase | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 4,358,478 11.3% | 9,650 (+0.22%) | View |
| 2024-06-07 4:18 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC BCYC | RA CAPITAL MANAGEMENT L.P. | 2,253,000 5% | 2,253,000 (New Position) | View |
| 2024-06-06 4:16 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 13,190,849 44.3% | 557 (+0.00%) | View |
| 2024-06-03 8:53 pm Purchase | 13G | Tourmaline Bio Inc. TRML | RA CAPITAL MANAGEMENT L.P. | 2,045,028 8% | 2,045,028 (New Position) | View |
| 2024-05-30 6:57 pm Purchase | 13G | Structure Therapeutics Inc. GPCR | RA CAPITAL MANAGEMENT L.P. | 7,225,311 5.2% | 7,225,311 (New Position) | View |
| 2024-05-17 4:18 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 13,190,292 45.3% | 556 (+0.00%) | View |
| 2024-05-14 9:10 pm Sale | 13D | iTeos Therapeutics Inc. ITOS | RA CAPITAL MANAGEMENT L.P. | 3,659,046 9.99% | -758,213 (-17.16%) | View |
| 2024-05-10 5:52 pm Purchase | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | RA CAPITAL MANAGEMENT L.P. | 7,714,760 9.99% | 7,714,760 (New Position) | View |
| 2024-05-09 8:48 pm Purchase | 13D | Black Diamond Therapeutics Inc. BDTX | RA CAPITAL MANAGEMENT L.P. | 2,788,028 4.95% | 198,124 (+7.65%) | View |
| 2024-05-07 4:52 pm Purchase | 13D | Werewolf Therapeutics Inc. HOWL | RA CAPITAL MANAGEMENT L.P. | 6,192,881 14.2% | 13,846 (+0.22%) | View |
| 2024-05-06 5:57 pm Purchase | 13G | Avidity Biosciences Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 4,895,959 5.1% | 2,441,426 (+99.47%) | View |
| 2024-05-02 5:58 pm Purchase | 13G | Zura Bio Ltd ZURA | RA CAPITAL MANAGEMENT L.P. | 3,217,503 5.1% | 3,217,503 (New Position) | View |
| 2024-04-30 4:16 pm Purchase | 13D | Aerovate Therapeutics Inc. AVTE | RA CAPITAL MANAGEMENT L.P. | 8,313,982 28.9% | 20,834 (+0.25%) | View |